Updated on 7 September 2026
Preclinical and Clinical Due Diligence
Legal Representative AKROS Bioscience at AKROS BIOSCIENCE SRL
POMEZIA, Italy
About
We provide independent preclinical and clinical due diligence for innovative healthcare projects, critically assessing available evidence, identifying development gaps and highlighting key scientific and clinical risks.
Our review helps companies, investors and potential partners understand the real maturity of a product, the strength of its supporting data and the additional evidence required to move development forward.
The assessment may cover preclinical packages, clinical data, study design, endpoints, consistency of the evidence and overall development strategy.
The result is a clear, decision-oriented evaluation designed to support investment, licensing, partnering and development decisions with a stronger understanding of both opportunities and risks.
Type
- Innovation management
- Consulting
- Research & Development
Organisation
Similar opportunities
Service
From Scientific Evidence to Regulatory Documentation
Salvatore Bianco
Legal Representative AKROS Bioscience at AKROS BIOSCIENCE SRL
POMEZIA, Italy
Service
Regulatory Roadmap for Innovative Products
- Consulting
- Innovation management
- Research & Development
Salvatore Bianco
Legal Representative AKROS Bioscience at AKROS BIOSCIENCE SRL
POMEZIA, Italy
Expertise
NAM Evidence, Regulatory Science and Translational Strategy
Marco Straccia
Managing Director at FRESCI by SCIENCE&STRATEGY SL
Terrassa, Spain